Veeva Systems Inc. (NYSE: VEEV) Stock Competitors & Peer Comparison
See VEEV's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for VEEV and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| VEEV | $195.38 | -1.01% | 31.7B | 23.46 | $8.33 | N/A |
| GEHC | $63.07 | -4.00% | 28.7B | 13.83 | $4.56 | +0.22% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $70.69 | +3.71% | 13.9B | 57.01 | $1.24 | N/A |
| BTSGU | $231.53 | +1.23% | 13.5B | 209.36 | $1.11 | N/A |
| TEM | $52.47 | -2.09% | 9.2B | -104.94 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $97.67 | +2.73% | 8.3B | 23.06 | $4.28 | N/A |
| HNGE | $87.09 | +1.29% | 6.7B | 44.66 | $1.95 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
VEEV vs GEHC Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, GEHC has a market cap of 28.7B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while GEHC trades at $63.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas GEHC's P/E ratio is 13.83. In terms of profitability, VEEV's ROE is +0.13%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, VEEV is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
VEEV vs GEHCV Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas GEHCV's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.13%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, VEEV is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
VEEV vs BTSG Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, BTSG has a market cap of 13.9B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while BTSG trades at $70.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas BTSG's P/E ratio is 57.01. In terms of profitability, VEEV's ROE is +0.13%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, VEEV is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
VEEV vs BTSGU Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, BTSGU has a market cap of 13.5B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while BTSGU trades at $231.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas BTSGU's P/E ratio is 209.36. In terms of profitability, VEEV's ROE is +0.13%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, VEEV is less volatile compared to BTSGU. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check BTSGU's competition here
Tempus AI, Inc. (NASDAQ: TEM)
VEEV vs TEM Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, TEM has a market cap of 9.2B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while TEM trades at $52.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas TEM's P/E ratio is -104.94. In terms of profitability, VEEV's ROE is +0.13%, compared to TEM's ROE of -0.70%. Regarding short-term risk, VEEV is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
VEEV vs SGFY Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas SGFY's P/E ratio is 70.91. In terms of profitability, VEEV's ROE is +0.13%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, VEEV is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
VEEV vs HQY Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, HQY has a market cap of 8.3B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while HQY trades at $97.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas HQY's P/E ratio is 23.06. In terms of profitability, VEEV's ROE is +0.13%, compared to HQY's ROE of +0.11%. Regarding short-term risk, VEEV is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check HQY's competition here
Hinge Health, Inc. (NYSE: HNGE)
VEEV vs HNGE Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, HNGE has a market cap of 6.7B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while HNGE trades at $87.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas HNGE's P/E ratio is 44.66. In terms of profitability, VEEV's ROE is +0.13%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, VEEV is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
VEEV vs RCM Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, RCM has a market cap of 6B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas RCM's P/E ratio is -102.21. In terms of profitability, VEEV's ROE is +0.13%, compared to RCM's ROE of +0.00%. Regarding short-term risk, VEEV is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
VEEV vs TXG Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, TXG has a market cap of 5.6B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while TXG trades at $43.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas TXG's P/E ratio is -257.29. In terms of profitability, VEEV's ROE is +0.13%, compared to TXG's ROE of -0.03%. Regarding short-term risk, VEEV is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check TXG's competition here
Doximity, Inc. (NYSE: DOCS)
VEEV vs DOCS Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, DOCS has a market cap of 4B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while DOCS trades at $21.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas DOCS's P/E ratio is 14.07. In terms of profitability, VEEV's ROE is +0.13%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, VEEV is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
VEEV vs ONEM Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas ONEM's P/E ratio is -7.77. In terms of profitability, VEEV's ROE is +0.13%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, VEEV is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
VEEV vs PRVA Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, PRVA has a market cap of 3.4B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while PRVA trades at $26.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas PRVA's P/E ratio is 168.13. In terms of profitability, VEEV's ROE is +0.13%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, VEEV is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
VEEV vs PGNY Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, PGNY has a market cap of 2.5B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while PGNY trades at $31.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas PGNY's P/E ratio is 23.31. In terms of profitability, VEEV's ROE is +0.13%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, VEEV is less volatile compared to PGNY. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
VEEV vs HTFL Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, HTFL has a market cap of 2.2B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while HTFL trades at $24.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas HTFL's P/E ratio is -12.92. In terms of profitability, VEEV's ROE is +0.13%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, VEEV is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
VEEV vs WGS Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, WGS has a market cap of 1.9B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while WGS trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas WGS's P/E ratio is 74.68. In terms of profitability, VEEV's ROE is +0.13%, compared to WGS's ROE of -0.28%. Regarding short-term risk, VEEV is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check WGS's competition here
Teladoc Health, Inc. (NYSE: TDOC)
VEEV vs TDOC Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, TDOC has a market cap of 1.7B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while TDOC trades at $9.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas TDOC's P/E ratio is -10.47. In terms of profitability, VEEV's ROE is +0.13%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, VEEV is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check TDOC's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
VEEV vs NXGN Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas NXGN's P/E ratio is -266.00. In terms of profitability, VEEV's ROE is +0.13%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, VEEV is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check NXGN's competition here
Omada Health (NASDAQ: OMDA)
VEEV vs OMDA Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while OMDA trades at $23.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas OMDA's P/E ratio is 338.57. In terms of profitability, VEEV's ROE is +0.13%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, VEEV is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
VEEV vs AGTI Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas AGTI's P/E ratio is -71.79. In terms of profitability, VEEV's ROE is +0.13%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, VEEV is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
VEEV vs GDRX Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, GDRX has a market cap of 1.1B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while GDRX trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas GDRX's P/E ratio is 9.52. In terms of profitability, VEEV's ROE is +0.13%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, VEEV is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check GDRX's competition here
Certara, Inc. (NASDAQ: CERT)
VEEV vs CERT Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while CERT trades at $6.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas CERT's P/E ratio is 17.77. In terms of profitability, VEEV's ROE is +0.13%, compared to CERT's ROE of -0.01%. Regarding short-term risk, VEEV is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check CERT's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
VEEV vs CCLDO Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas CCLDO's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.13%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, VEEV is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
VEEV vs HSTM Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, HSTM has a market cap of 845.5M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while HSTM trades at $28.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas HSTM's P/E ratio is 38.08. In terms of profitability, VEEV's ROE is +0.13%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, VEEV is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check HSTM's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
VEEV vs WGSWW Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, WGSWW has a market cap of 748M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas WGSWW's P/E ratio is -0.02. In terms of profitability, VEEV's ROE is +0.13%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, VEEV is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check WGSWW's competition here
Phreesia, Inc. (NYSE: PHR)
VEEV vs PHR Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, PHR has a market cap of 662M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while PHR trades at $10.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas PHR's P/E ratio is 38.25. In terms of profitability, VEEV's ROE is +0.13%, compared to PHR's ROE of +0.03%. Regarding short-term risk, VEEV is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check PHR's competition here
Evolent Health, Inc. (NYSE: EVH)
VEEV vs EVH Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, EVH has a market cap of 652.4M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while EVH trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas EVH's P/E ratio is 580.00. In terms of profitability, VEEV's ROE is +0.13%, compared to EVH's ROE of -0.78%. Regarding short-term risk, VEEV is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check EVH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
VEEV vs MPLN-WT Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.13%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, VEEV is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
VEEV vs ACCD Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas ACCD's P/E ratio is -3.08. In terms of profitability, VEEV's ROE is +0.13%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, VEEV is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
VEEV vs SHCR Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas SHCR's P/E ratio is -3.76. In terms of profitability, VEEV's ROE is +0.13%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, VEEV is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check SHCR's competition here
Claritev Corporation (NYSE: CTEV)
VEEV vs CTEV Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, CTEV has a market cap of 517.5M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while CTEV trades at $30.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas CTEV's P/E ratio is -2.33. In terms of profitability, VEEV's ROE is +0.13%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, VEEV is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check CTEV's competition here
NRC Health (NASDAQ: NRC)
VEEV vs NRC Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, NRC has a market cap of 490.8M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while NRC trades at $21.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas NRC's P/E ratio is 26.56. In terms of profitability, VEEV's ROE is +0.13%, compared to NRC's ROE of +0.57%. Regarding short-term risk, VEEV is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check NRC's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
VEEV vs SOPH Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, SOPH has a market cap of 403.5M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while SOPH trades at $5.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas SOPH's P/E ratio is -11.29. In terms of profitability, VEEV's ROE is +0.13%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, VEEV is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check SOPH's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
VEEV vs SLGCW Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, VEEV's ROE is +0.13%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, VEEV is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check SLGCW's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
VEEV vs SLGC Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas SLGC's P/E ratio is -3.04. In terms of profitability, VEEV's ROE is +0.13%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, VEEV is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check SLGC's competition here
TruBridge, Inc. (NASDAQ: TBRG)
VEEV vs TBRG Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas TBRG's P/E ratio is 9.37. In terms of profitability, VEEV's ROE is +0.13%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, VEEV is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
VEEV vs MPLN Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas MPLN's P/E ratio is -0.23. In terms of profitability, VEEV's ROE is +0.13%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, VEEV is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
VEEV vs SLP Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, SLP has a market cap of 368.7M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while SLP trades at $18.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas SLP's P/E ratio is 20.72. In terms of profitability, VEEV's ROE is +0.13%, compared to SLP's ROE of +0.06%. Regarding short-term risk, VEEV is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check SLP's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
VEEV vs TRHC Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas TRHC's P/E ratio is -4.27. In terms of profitability, VEEV's ROE is +0.13%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, VEEV is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
VEEV vs SMFR Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas SMFR's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.13%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, VEEV is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
VEEV vs SPOK Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, SPOK has a market cap of 222.2M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while SPOK trades at $10.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas SPOK's P/E ratio is 17.73. In terms of profitability, VEEV's ROE is +0.13%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, VEEV is less volatile compared to SPOK. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check SPOK's competition here
So-Young International Inc. (NASDAQ: SY)
VEEV vs SY Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, SY has a market cap of 220.4M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while SY trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas SY's P/E ratio is -5.09. In terms of profitability, VEEV's ROE is +0.13%, compared to SY's ROE of -0.16%. Regarding short-term risk, VEEV is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check SY's competition here
American Well Corporation (NYSE: AMWL)
VEEV vs AMWL Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, AMWL has a market cap of 220.3M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while AMWL trades at $13.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas AMWL's P/E ratio is -2.54. In terms of profitability, VEEV's ROE is +0.13%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, VEEV is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
VEEV vs HCAT Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, HCAT has a market cap of 166.3M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while HCAT trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas HCAT's P/E ratio is 11.25. In terms of profitability, VEEV's ROE is +0.13%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, VEEV is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
VEEV vs CPSI Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas CPSI's P/E ratio is -183.80. In terms of profitability, VEEV's ROE is +0.13%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, VEEV is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
VEEV vs OPRX Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, OPRX has a market cap of 125.5M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while OPRX trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas OPRX's P/E ratio is 6.14. In terms of profitability, VEEV's ROE is +0.13%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, VEEV is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
VEEV vs AUGX Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas AUGX's P/E ratio is -4.99. In terms of profitability, VEEV's ROE is +0.13%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, VEEV is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
VEEV vs CCLD Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, CCLD has a market cap of 98.6M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while CCLD trades at $2.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas CCLD's P/E ratio is 8.59. In terms of profitability, VEEV's ROE is +0.13%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, VEEV is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
VEEV vs DH Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, DH has a market cap of 80.1M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while DH trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas DH's P/E ratio is 2.92. In terms of profitability, VEEV's ROE is +0.13%, compared to DH's ROE of -0.67%. Regarding short-term risk, VEEV is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
VEEV vs FORA Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas FORA's P/E ratio is -24.11. In terms of profitability, VEEV's ROE is +0.13%, compared to FORA's ROE of -0.17%. Regarding short-term risk, VEEV is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
VEEV vs CCLDP Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas CCLDP's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.13%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, VEEV is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
VEEV vs ONMD Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, ONMD has a market cap of 38.7M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while ONMD trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas ONMD's P/E ratio is -4.53. In terms of profitability, VEEV's ROE is +0.13%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, VEEV is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
VEEV vs SNCE Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas SNCE's P/E ratio is -0.27. In terms of profitability, VEEV's ROE is +0.13%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, VEEV is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
VEEV vs AKLI Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas AKLI's P/E ratio is -0.71. In terms of profitability, VEEV's ROE is +0.13%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, VEEV is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
VEEV vs SHLT Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas SHLT's P/E ratio is -3.87. In terms of profitability, VEEV's ROE is +0.13%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, VEEV is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
VEEV vs SHCRW Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, VEEV's ROE is +0.13%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, VEEV is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
VEEV vs ONMDW Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, ONMDW has a market cap of 27.7M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas ONMDW's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.13%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, VEEV is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
VEEV vs STRM Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas STRM's P/E ratio is -2.40. In terms of profitability, VEEV's ROE is +0.13%, compared to STRM's ROE of -0.32%. Regarding short-term risk, VEEV is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
VEEV vs RNLX Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas RNLX's P/E ratio is -0.33. In terms of profitability, VEEV's ROE is +0.13%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, VEEV is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
VEEV vs LIFW Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas LIFW's P/E ratio is -0.02. In terms of profitability, VEEV's ROE is +0.13%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, VEEV is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check LIFW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
VEEV vs EUDA Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, EUDA has a market cap of 21.1M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while EUDA trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas EUDA's P/E ratio is -21.32. In terms of profitability, VEEV's ROE is +0.13%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, VEEV is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check EUDA's competition here
Babylon Holdings Limited (NYSE: BBLN)
VEEV vs BBLN Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas BBLN's P/E ratio is -0.04. In terms of profitability, VEEV's ROE is +0.13%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, VEEV is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check BBLN's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
VEEV vs BEATW Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, BEATW has a market cap of 13.4M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while BEATW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas BEATW's P/E ratio is -0.04. In terms of profitability, VEEV's ROE is +0.13%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, VEEV is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check BEATW's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
VEEV vs ETAO Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas ETAO's P/E ratio is -0.01. In terms of profitability, VEEV's ROE is +0.13%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, VEEV is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
VEEV vs BFRG Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, BFRG has a market cap of 7.5M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while BFRG trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas BFRG's P/E ratio is -1.20. In terms of profitability, VEEV's ROE is +0.13%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, VEEV is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check BFRG's competition here
Cue Health Inc. (NASDAQ: HLTH)
VEEV vs HLTH Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, HLTH has a market cap of 6.9M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while HLTH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas HLTH's P/E ratio is -0.02. In terms of profitability, VEEV's ROE is +0.13%, compared to HLTH's ROE of -0.90%. Regarding short-term risk, VEEV is less volatile compared to HLTH. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check HLTH's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
VEEV vs SCNX Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, SCNX has a market cap of 6.4M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while SCNX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas SCNX's P/E ratio is -0.16. In terms of profitability, VEEV's ROE is +0.13%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, VEEV is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH)
VEEV vs UPH Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas UPH's P/E ratio is -0.07. In terms of profitability, VEEV's ROE is +0.13%, compared to UPH's ROE of -1.05%. Regarding short-term risk, VEEV is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
VEEV vs UPH-WT Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.13%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, VEEV is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check UPH-WT's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
VEEV vs MGRX Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, MGRX has a market cap of 4.2M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while MGRX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas MGRX's P/E ratio is -0.31. In terms of profitability, VEEV's ROE is +0.13%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, VEEV is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
VEEV vs PEAR Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas PEAR's P/E ratio is -0.08. In terms of profitability, VEEV's ROE is +0.13%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, VEEV is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
VEEV vs PEARW Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas PEARW's P/E ratio is -0.00. In terms of profitability, VEEV's ROE is +0.13%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, VEEV is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
VEEV vs OTRK Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas OTRK's P/E ratio is -0.02. In terms of profitability, VEEV's ROE is +0.13%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, VEEV is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check OTRK's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
VEEV vs VSEEW Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, VSEEW has a market cap of 2.2M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while VSEEW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas VSEEW's P/E ratio is -0.06. In terms of profitability, VEEV's ROE is +0.13%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, VEEV is more volatile compared to VSEEW. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check VSEEW's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
VEEV vs HCTI Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, HCTI has a market cap of 2.1M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while HCTI trades at $1.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas HCTI's P/E ratio is -0.23. In terms of profitability, VEEV's ROE is +0.13%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, VEEV is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
VEEV vs CMAX Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas CMAX's P/E ratio is -0.00. In terms of profitability, VEEV's ROE is +0.13%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, VEEV is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEE)
VEEV vs VSEE Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, VSEE has a market cap of 1.6M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while VSEE trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas VSEE's P/E ratio is -0.19. In terms of profitability, VEEV's ROE is +0.13%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, VEEV is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check VSEE's competition here
Aclarion, Inc. (NASDAQ: ACON)
VEEV vs ACON Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while ACON trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas ACON's P/E ratio is -0.24. In terms of profitability, VEEV's ROE is +0.13%, compared to ACON's ROE of -0.54%. Regarding short-term risk, VEEV is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
VEEV vs LIFWZ Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.13%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, VEEV is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
VEEV vs EUDAW Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, VEEV's ROE is +0.13%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, VEEV is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
VEEV vs WORX Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, WORX has a market cap of 693.4K. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while WORX trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas WORX's P/E ratio is -0.76. In terms of profitability, VEEV's ROE is +0.13%, compared to WORX's ROE of -0.65%. Regarding short-term risk, VEEV is more volatile compared to WORX. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
VEEV vs MSPRZ Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.13%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, VEEV is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
VEEV vs KERN Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas KERN's P/E ratio is -0.01. In terms of profitability, VEEV's ROE is +0.13%, compared to KERN's ROE of -0.17%. Regarding short-term risk, VEEV is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
VEEV vs KERNW Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas KERNW's P/E ratio is -0.00. In terms of profitability, VEEV's ROE is +0.13%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, VEEV is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
VEEV vs LIFWW Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas LIFWW's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.13%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, VEEV is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
VEEV vs ZCMD Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, ZCMD has a market cap of 58K. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while ZCMD trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas ZCMD's P/E ratio is -0.06. In terms of profitability, VEEV's ROE is +0.13%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, VEEV is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
VEEV vs CMAXW Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas CMAXW's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.13%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, VEEV is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
VEEV vs ACONW Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, ACONW has a market cap of 11.7K. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas ACONW's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.13%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, VEEV is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check ACONW's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
VEEV vs MTBCO Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas MTBCO's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.13%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, VEEV is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check MTBCO's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
VEEV vs MSPRV Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas MSPRV's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.13%, compared to MSPRV's ROE of N/A. Regarding short-term risk, VEEV is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
VEEV vs MTBCP Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas MTBCP's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.13%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, VEEV is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
VEEV vs MTBC Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, MTBC has a market cap of 0. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas MTBC's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.13%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, VEEV is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check MTBC's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
VEEV vs CHNG Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, CHNG has a market cap of 0. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas CHNG's P/E ratio is -152.72. In terms of profitability, VEEV's ROE is +0.13%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, VEEV is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check CHNG's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
VEEV vs CHNGU Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas CHNGU's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.13%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, VEEV is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check CHNGU's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
VEEV vs CNVY Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, CNVY has a market cap of 0. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas CNVY's P/E ratio is -71.50. In terms of profitability, VEEV's ROE is +0.13%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, VEEV is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check CNVY's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
VEEV vs NAVA Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, NAVA has a market cap of 0. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas NAVA's P/E ratio is N/A. In terms of profitability, VEEV's ROE is +0.13%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, VEEV is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for VEEV.Check NAVA's competition here
Cerner Corporation (NASDAQ: CERN)
VEEV vs CERN Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, CERN has a market cap of 0. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas CERN's P/E ratio is 55.84. In terms of profitability, VEEV's ROE is +0.13%, compared to CERN's ROE of +0.14%. Regarding short-term risk, VEEV is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check CERN's competition here
Castlight Health, Inc. (NYSE: CSLT)
VEEV vs CSLT Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, CSLT has a market cap of 0. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas CSLT's P/E ratio is -37.27. In terms of profitability, VEEV's ROE is +0.13%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, VEEV is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for VEEV.Check CSLT's competition here
NantHealth, Inc. (NASDAQ: NH)
VEEV vs NH Comparison July 2026
Veeva Systems Inc. (NYSE: VEEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VEEV stands at 31.7B. In comparison, NH has a market cap of 0. Regarding current trading prices, VEEV is priced at $195.38 on the NYSE, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VEEV currently has a P/E ratio of 23.46, whereas NH's P/E ratio is -0.12. In terms of profitability, VEEV's ROE is +0.13%, compared to NH's ROE of +0.35%. Regarding short-term risk, VEEV is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for VEEV.Check NH's competition here